However, following PD-L1 knockout, both CSC and non-CSC populations showed similar levels of cleaved caspase 3 (Supplementary Fig. 1d), suggesting that the enhanced PD-L1 expression in CSCs contributes to CSC resistance to PBMC-mediated killing in vitro in our breast cancer model system. Here, CASP3 is linked to breast cancer.